tm
Seeing Is Believing
tm
Seeing Is Believing
LPTX is currently covered by 5 analysts with an average price target of $15.23. This is a potential upside of $12.25 (411.07%) from yesterday's end of day stock price of $2.98.
Leap Therapeutics's activity chart (see below) currently has 13 price targets and 31 ratings on display. The stock rating distribution of LPTX is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 26.19% with an average time for these price targets to be met of 166 days.
Highest price target for LPTX is $7, Lowest price target is $7, average price target is $15.23.
Most recent stock forecast was given by MARA GOLDSTEIN from MIZUHO on 20-Nov-2023. First documented stock forecast 12-Apr-2018.
Currently out of the existing stock ratings of LPTX, 19 are a BUY (100%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
20
4 months 28 days ago
0/3 (0%)
$15.8 (376.19%)
Buy
5 months 3 days ago
2/4 (50%)
$13.21 (348.55%)
115
Buy
5 months 3 days ago
0/1 (0%)
$33.9 (210.56%)
Buy
7
$4.42 (171.32%)
25
8 months 2 days ago
0/3 (0%)
$4.46 (175.59%)
Buy
1 years 3 months ago
1/3 (33.33%)
$28.9 (260.36%)
669
What is LPTX (Leap Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on LPTX (Leap Therapeutics) with a proven track record?
Which analyst has the current lower performing score on LPTX (Leap Therapeutics) with a proven track record?
Which analyst has the most public recommendations on LPTX (Leap Therapeutics)?
Which analyst is the currently most bullish on LPTX (Leap Therapeutics)?
Which analyst is the currently most reserved on LPTX (Leap Therapeutics)?
